Steve Nicholson

1.5k total citations
34 papers, 994 citations indexed

About

Steve Nicholson is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Steve Nicholson has authored 34 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Steve Nicholson's work include Genital Health and Disease (9 papers), Urological Disorders and Treatments (5 papers) and Urologic and reproductive health conditions (5 papers). Steve Nicholson is often cited by papers focused on Genital Health and Disease (9 papers), Urological Disorders and Treatments (5 papers) and Urologic and reproductive health conditions (5 papers). Steve Nicholson collaborates with scholars based in United Kingdom, United States and Canada. Steve Nicholson's co-authors include Emma Hall, Amit Bahl, Poulam M. Patel, Paul Nathan, A.B. Alexandroff, Andrew M. Jackson, Ian Clarke, Angus Dalgleish, Agamemnon A. Epenetos and Nick Watkin and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

Steve Nicholson

34 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Nicholson United Kingdom 16 361 330 257 184 132 34 994
Kjell Bergfeldt Sweden 16 207 0.6× 337 1.0× 331 1.3× 123 0.7× 175 1.3× 28 1.1k
José María Sayagués Spain 23 367 1.0× 292 0.9× 202 0.8× 108 0.6× 131 1.0× 66 1.3k
Petr Szturz Czechia 18 269 0.7× 494 1.5× 307 1.2× 129 0.7× 350 2.7× 85 1.2k
Martin‐Leo Hansmann Germany 18 163 0.5× 530 1.6× 143 0.6× 352 1.9× 182 1.4× 27 1.3k
Melanie J. McCoy Australia 16 218 0.6× 323 1.0× 92 0.4× 324 1.8× 164 1.2× 28 1.0k
P H de Mulder Netherlands 13 201 0.6× 322 1.0× 272 1.1× 220 1.2× 145 1.1× 18 754
Fredrik Enlund Sweden 18 210 0.6× 555 1.7× 444 1.7× 526 2.9× 231 1.8× 31 1.4k
Anna Novarino Italy 19 294 0.8× 577 1.7× 91 0.4× 319 1.7× 111 0.8× 43 1.1k
S. David Nathanson United States 19 235 0.7× 642 1.9× 172 0.7× 150 0.8× 159 1.2× 41 1.2k
Jerrold B. Teitcher United States 18 313 0.9× 374 1.1× 523 2.0× 82 0.4× 353 2.7× 22 1.3k

Countries citing papers authored by Steve Nicholson

Since Specialization
Citations

This map shows the geographic impact of Steve Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Nicholson more than expected).

Fields of papers citing papers by Steve Nicholson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Nicholson. The network helps show where Steve Nicholson may publish in the future.

Co-authorship network of co-authors of Steve Nicholson

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Nicholson. A scholar is included among the top collaborators of Steve Nicholson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Nicholson. Steve Nicholson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicholson, Steve, Juanita Crook, Nick Watkin, et al.. (2025). Standardization of Radiation Therapy to Inguinal and Pelvic Lymph Nodes in Locally Advanced Cancer of the Penis, as Defined by the International Penile Advanced Cancer Trial (InPACT). International Journal of Radiation Oncology*Biology*Physics. 123(1). 171–182. 1 indexed citations
2.
Zemp, Logan, et al.. (2024). Management of Bulky Inguinal and Pelvic Lymph Nodes. Urologic Clinics of North America. 51(3). 335–345. 1 indexed citations
3.
Nicholson, Steve, Holly Tovey, Tony Elliott, et al.. (2021). VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis. British Journal of Cancer. 126(1). 34–41. 8 indexed citations
4.
Canter, Daniel, Steve Nicholson, Nick Watkin, Emma Hall, & Curtis A. Pettaway. (2019). The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status. European Urology Focus. 5(5). 706–709. 46 indexed citations
5.
Corrie, Pippa, Andrea Marshall, Janet Dunn, et al.. (2014). Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study. The Lancet Oncology. 15(6). 620–630. 75 indexed citations
6.
Nicholson, Steve, Emma Hall, S.J. Harland, et al.. (2013). Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001). British Journal of Cancer. 109(10). 2554–2559. 84 indexed citations
7.
Lorigan, Paul, Maria Marples, Mark Harries, et al.. (2013). Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study. British Journal of Dermatology. 170(1). 87–95. 10 indexed citations
8.
Eisen, Tim, Heikki Joensuu, Paul Nathan, et al.. (2012). Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial. The Lancet Oncology. 13(10). 1055–1062. 84 indexed citations
9.
Nicholson, Steve. (2011). Chemotherapy for bladder cancer in patients with impaired renal function. Nature Reviews Urology. 9(1). 52–57. 15 indexed citations
10.
Joensuu, Heikki, Paul Nathan, Peter Harper, et al.. (2011). 7141 POSTER Phase II Trial of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as First-line Therapy in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC). European Journal of Cancer. 47. S517–S517. 8 indexed citations
11.
Cook, Natalie, Bristi Basu, Swethajit Biswas, et al.. (2010). A phase 2 study of vatalanib in metastatic melanoma patients. European Journal of Cancer. 46(15). 2671–2673. 23 indexed citations
12.
Joensuu, Heikki, Paul Nathan, Peter Harper, et al.. (2009). 7105 Phase II trial of the oral multikinase inhibitor BAY 73–4506 as 1st-line therapy in patients with metastatic or unresectable renal cell cancer (RCC). European Journal of Cancer Supplements. 7(2). 424–424. 12 indexed citations
13.
Nicholson, Steve, David Tsang, & Duncan J. Summerton. (2008). Aggressive combined-modality therapy for squamous cell carcinoma of the female urethra. Nature Clinical Practice Urology. 5(10). 574–577. 5 indexed citations
14.
Bartlett, J. Blake, Ian Clarke, Keith Dredge, et al.. (2004). Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers. British Journal of Cancer. 90(5). 955–961. 123 indexed citations
15.
Nicholson, Steve, et al.. (2004). Does Knowledge Influence Melanoma-Prone Behavior? Awareness, Exposure, and Sun Protection Among Five Social Groups. Oncology nursing forum. 31(3). 641–646. 26 indexed citations
16.
Nicholson, Steve, H. Thomas, Angus McIndoe, et al.. (2004). A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer. Cancer Immunology Immunotherapy. 53(9). 809–16. 34 indexed citations
17.
Nicholson, Steve, et al.. (2003). A randomized phase II trial of SRL172 (Mycobacterium vaccae) ± low-dose interleukin-2 in the treatment of metastatic malignant melanoma. Melanoma Research. 13(4). 389–393. 21 indexed citations
18.
Eaton, J.D., Matthew Perry, Steve Nicholson, et al.. (2002). Allogeneic whole‐cell vaccine: a phase I/II study in men with hormone‐refractory prostate cancer. British Journal of Urology. 89(1). 19–26. 56 indexed citations
19.
Balesaria, Sara, C. Brock, Mark Bower, et al.. (1999). Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. British Journal of Cancer. 81(8). 1371–1377. 54 indexed citations
20.
Bower, Mark, F.J. Paradinas, Rosemary A. Fisher, et al.. (1996). Placental site trophoblastic tumor: molecular analysis and clinical experience.. PubMed. 2(5). 897–902. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kjell Bergfeldt Breakdown of academic impact, for papers by José María Sayagués Breakdown of academic impact, for papers by Petr Szturz Breakdown of academic impact, for papers by Martin‐Leo Hansmann Breakdown of academic impact, for papers by Melanie J. McCoy Breakdown of academic impact, for papers by P H de Mulder Breakdown of academic impact, for papers by Fredrik Enlund Breakdown of academic impact, for papers by Anna Novarino Breakdown of academic impact, for papers by S. David Nathanson Breakdown of academic impact, for papers by Jerrold B. Teitcher
Rankless by CCL
2026